AstraZeneca (AstraZeneca) EBITDA Margin %

: 18.12% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

EBITDA Margin % is calculated as EBITDA divided by its Revenue. AstraZeneca's EBITDA for the three months ended in Dec. 2023 was $2,179 Mil. AstraZeneca's Revenue for the three months ended in Dec. 2023 was $12,024 Mil. Therefore, AstraZeneca's EBITDA margin for the quarter that ended in Dec. 2023 was 18.12%.

AstraZeneca EBITDA Margin % Historical Data

The historical data trend for AstraZeneca's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

27.53

30.37

13.66

20.48

29.30

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBITDA Margin %																21.20	37.95	33.24	28.94	18.12

Competitive Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca EBITDA Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where AstraZeneca's EBITDA Margin % falls into.

AstraZeneca EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

AstraZeneca's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	13422	/	45811
	=	29.30 %

AstraZeneca's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2179	/	12024
	=	18.12 %

AstraZeneca (NAS:AZN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

AstraZeneca EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of AstraZeneca's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.